What is eyemax mono ?
EyeMax Mono is the latest in LEH Pharma’s iolAMD range of lenses and is unique in its ability to improve vision in patients at all stages of both dry and stable wet age related macular degeneration. AMD is a disorder affecting the central part of the retina, causing changes to central vision and making everyday tasks difficult. It is the leading cause of blindness in people aged over 55 and affects nearly 200 million people worldwide.
EyeMax Mono is the worlds first micro-incision injectable Extended Macular Lens Implant. The innovative technology and unique optics of the EyeMax lens diverts images away from the damaged part of the eye and enhances them to the healthy parts, leading to a significant improvement of vision for patients. The shape of the Eyemax Lens redirects the same high quality image at every point of the retina, leaving the selection of the best alternative macula to the human brain.
The EyeMax procedure is simple, takes 30 minutes, and is as safe as routine cataract surgery. To date, over 2,000 implants have been carried out in more than 10 countries worldwide
Conceived by eye surgeon Dr Bobby Qureshi and optical physicist Professor Pablo Artal, EyeMax is a revolutionary breakthrough for AMD sufferers, capable of allowing patients to drive, see faces and read again - greatly improving their quality of life.